Fact CheckerSign in

NCT05565872Completed

Effects of Supervision During a Community-based Exercise Intervention (Urban Training) in Patients With COPD

Effects of Face-to-face Versus Telematic Supervision During a Community-based Exercise Intervention (Urban Training) Plus Therapeutic Education Programme on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 25 Nov 2024

Brief summary (registry, in English)

This project plans on a community-based exercise intervention (Urban Training) combined with therapeutic education program, by using public spaces and urban walkable trails, adapted to each patient needs and capabilities in patients with chronic obstructive pulmonary disease (COPD). The main objective of the present study is to evaluate the effects comparing different levels of supervision (face-to-face vs telematic) in the short-, medium- and long-term with respect to: (primary outcome): exercise capacity, and (secondary outcomes): physical activity, quality of life, mental health and COPD exacerbations.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
27 Sept 2022
Start date
5 Oct 2022
Primary completion date
20 Jun 2024
Lead sponsor
Universidad Complutense de Madrid
Diseases
COPD
NCT number
NCT05565872

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 5 Oct 2022 to the primary completion date, 20 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous inclusion in a rehabilitation programme (previous 6 months)

Other illness

  • Neuromuscular or neurological disorders and/or psychiatric or cognitive conditions that hindered they ability to cooperate

Other

  • Comorbidity that could interfere with study intervention (e.g., severe orthopaedic problems)

Who the study is looking for

  • age \> 18 years
  • COPD diagnosed by pulmonary function tests during clinical stability, with a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ≤ 0.70
  • Clinical stability, defined as at least 6 weeks without COPD exacerbation

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Zona Básica de Salud Torrejón de Ardoz
Coordinator of this site? Confirm its status
Torrejón de ArdozSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.